Independent Conference Coverage from The American Thoracic Society International Conference 2023*

Episode 1
AMA/ANCC/ACPE Activity - Clinical Clips
Despite dramatic advances in the development of treatments for pulmonary arterial hypertension (PAH), it remains a chronic life-threatening illness for which there is no cure. Advances in knowledge within the field are eagerly anticipated.
These educational Clinical Clips will spotlight important research into the basic science, diagnosis, treatment, and medical management of patients with PAH based on data presented at the American Thoracic Society (ATS) International Conference in Washington, DC, May 19-24, 2023.
FACULTY
Vijay Balasubramanian, MD, MRCP (UK)
Section Chair, Pulmonary Vascular Disease Network
American College of Chest Physicians (ACCP)
Review the activity at bit.ly/41V41sF and claim AMA, ANCC or ACPE credit/contact hour after completion of a brief pretest and posttest/evaluation.
This activity is jointly provided by the University of Nebraska Medical Center, Duquesne University School of Pharmacy and Practice Point Communications
Supported by independent educational grants from United Therapeutics, Bayer U.S. and Actelion Pharmaceuticals U.S., Inc., A Janssen Pharmaceutical Company of Johnson & Johnson
*This coverage is not sanctioned by the conference organizers and is not an official part of the conference proceedings of the American Thoracic Society (ATS) International Conference 2023.
#freecme #ats2023 #practicepointcme #pah #pulmonology #continuingmedicaleducation